Previously, we have shown that CD276-CAR NK-92 cells showed no undesirable off-target effects since CAR-mediated cytotoxicity only occurred in the presence of CD276 surface expression on target tumor cells [22]. The gene discussed is CD276; the disease is neoplasm.